CartiHeal Agili-C · Treatment comparison

CartiHeal vs ACI cartilage implantation

CartiHeal treats cartilage and underlying bone in one operation with an off-the-shelf scaffold. Traditional ACI is a two-stage cultured-cell treatment centred on the cartilage surface. The deciding issue is the defect—not simply the number of operations.

CartiHeal · after remodelling
ACI · matured cell repair
Matched healed femoral-condyle cutaways comparing CartiHeal osteochondral remodelling with mature ACI cartilage repair over intact subchondral bone
Illustrative successful repair outcomes after tissue maturation or remodelling. Individual healing varies; this image is explanatory, not a prediction.

Quick answer

CartiHeal uses an off-the-shelf biphasic scaffold in one operation. ACI harvests and expands the patient’s cartilage cells before a later implantation. There is no direct CartiHeal-versus-ACI trial establishing a universal winner.

Verified across three networks

Trusted by patients on Doctify, Google and Top Doctors

Core difference

CartiHeal is off the shelf; ACI grows the patient’s own cells

CartiHeal is a porous biphasic implant placed into a prepared cartilage-and-bone site in one operation. ACI starts with arthroscopic cartilage-cell harvest, followed by laboratory expansion and a later implantation operation.

The distinction is not simply one stage versus two. CartiHeal deliberately addresses an osteochondral unit, while ACI is a cell-based strategy centred on the cartilage surface and may need separate management of deeper bone pathology.

Treatment architecture

Ready-made scaffold or patient cell culture

CartiHeal

One-stage osteochondral scaffold

  • Cell-free implant available off the shelf
  • Prepared cylinder crosses cartilage and underlying bone
  • No biopsy or laboratory expansion stage

ACI

Two-stage cultured-cell pathway

  • Cartilage biopsy supplies the patient’s cells
  • Laboratory expansion occurs between operations
  • Implantation targets the cartilage-surface defect

Lesion-led choice

Four questions matter before stage count

How much bone is involved?

A deep osteochondral problem is not the same as a surface cartilage defect.

What is the defect geometry?

Size, shape, containment and location change the feasible repair.

What has already been done?

Previous marrow stimulation or repair can affect the tissue and next options.

Can the whole knee support it?

Alignment, stability, meniscus and arthritis still control the decision.

Which lesion fits?

Bone involvement, defect geometry and previous surgery can change the answer

CartiHeal may be relevant where a contained knee-joint surface lesion and its underlying bone can be prepared to accept the implant. ACI may suit selected larger chondral defects where cultured autologous cells and a staged pathway are proportionate.

Alignment, stability, meniscus function, osteoarthritis grade, prior marrow stimulation and rehabilitation capacity must be considered for either procedure. The device name should not lead the diagnosis.

Evidence boundaries

Separate evidence bases do not create a head-to-head winner

CartiHeal has randomised evidence against debridement or microfracture. That trial did not compare CartiHeal directly with ACI. ACI has a longer and different evidence history across varied techniques and patient groups.

A credible comparison therefore asks which population and lesion resembles the individual knee, rather than comparing headline outcome percentages from unrelated studies.

There is no direct CartiHeal-versus-ACI superiority claim supported by the pivotal CartiHeal trial.

Evidence boundaries

Separate literatures answer different questions

CartiHeal evidence

Randomised against debridement or microfracture control.

ACI evidence

Covers varied cultured-cell techniques, lesions and patient groups.

No direct superiority claim

The pivotal CartiHeal trial did not include an ACI arm.

Compare the relevant patient

Study populations must resemble the lesion being considered.

Side-by-side

Off-the-shelf scaffold or cultured cells?

Question
CartiHeal
ACI
Stages
One operation
Cell harvest then later implantation
Biological input
Cell-free porous scaffold
Patient’s cultured cartilage cells
Bone strategy
Biphasic osteochondral implant
May require separate bone management
Availability
Off the shelf in selected sizes
Requires laboratory expansion
Direct trial
No direct ACI comparison
No direct CartiHeal comparison
Scientist preparing cultured cartilage cells in a clinical laboratory

CartiHeal and ACI questions

Is CartiHeal a form of ACI?

No. CartiHeal is a cell-free osteochondral scaffold; ACI uses the patient’s cultured chondrocytes in a staged pathway.

Does CartiHeal avoid cell harvest?

Yes. It is off the shelf and does not require an initial cartilage biopsy for laboratory expansion.

Is CartiHeal proven better than ACI?

Not by the pivotal CartiHeal trial, which compared the implant with debridement or microfracture rather than ACI.

Which has the shorter treatment pathway?

CartiHeal is performed in one operation. ACI normally requires a harvest and later implantation, although rehabilitation remains substantial for both.

Still have more specific concerns?

Free Discovery Call

Options that our doctors may discuss include NanoACi, ChondroFiller, Mytocel MSK, joint replacement, established conservative care or surgery, depending on examination and imaging.

Match the repair strategy to the lesion

Professor Lee can compare CartiHeal, ACI and other cartilage-restoration routes against your imaging, goals and whole-knee mechanics.

Privacy & Cookies Policy